Notable raises $100M to automate administrative tasks
The workflow automation startup has struck partnerships with large health systems, including Intermountain Healthcare and CommonSpirit Health.
Biotech Hub
Postdoctoral scientist t@ the Xavier Saelens Lab
VIB is a life sciences research institute, based in Flanders, Belgium. We perform basic research with a strong focus on translating scientific results into pharmaceutical, agricultural and industrial…
Postdoctoral positions in spatial-omics
Fully funded postdoctoral positions are available in the Nir Lab within the Department of Biochemistry & Molecular Biology at the University of Texas Medical Branch.Our lab studies the relationship…
Black In Immuno: harnessing social media and digital platforms to connect the dots
Black In Immuno harnesses social media and digital platforms to connect Black immunologists with one another and with the rest of the scientific ecosystem. We invite you to join us, to connect with…
Executive Director, Translational Immunology
Join a Team that Lives to Improve Lives People come to Genentech from across disciplines and across the world to solve our most challenging medical conditions. You’ll find inspiration in our passion…
Little droplets make the ocean of drug discovery
How sound waves can speed up the quest for new medicines
Sharp’s 108-inch LCD television, a 10,000-lumen projector from Panasonic, and more
Nature Photonics – Sharp’s 108-inch LCD television, a 10,000-lumen projector from Panasonic, and…
Investor perspective: How to successfully partner with in-demand healthcare startups
A private equity investor shares his advice on how to work with hot startups and find a seat at their investing table.
Amgen breaks ground on New Albany, OH manufacturing plant of the future — report
Amgen announced back in June that it would spend $365 million to build its manufacturing plant of the future in New Albany, OH, complete with self-driving vehicles and data-gathering tools to ensure…
San Fran biotech gets another blow to lead drug; Swiss biotech raises $49 million in Series A — with help from big venture
In the wake of Calithera Biosciences axing a third of its workforce in January over a failed Phase II trial with lead drug telaglenastat in patients with renal cell carcinoma, they just got slammed…